Gene Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Therapy stocks.

Gene Therapy Stocks Recent News

Date Stock Title
May 10 XENE Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript
May 10 FDMT 4D Molecular Therapeutics Inc (FDMT) Q1 2024 Earnings: Misses Analyst Net Income Projections
May 10 XENE Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ...
May 10 MRVI Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 10 XENE Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
May 10 NGNE Neurogene GAAP EPS of -$1.00 beats by $0.03
May 10 NGNE Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
May 10 XENE Xenon Pharmaceuticals Inc. (XENE) Q1 2024 Earnings Call Transcript
May 9 FDMT 4D Molecular Therapeutics reports Q1 results
May 9 XENE Xenon Pharma GAAP EPS of -$0.62 beats by $0.05
May 9 MRVI Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
May 9 MRVI Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
May 9 FDMT 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
May 9 XENE Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 9 MRVI Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
May 9 MRVI Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
May 9 MRVI Maravai LifeSciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 9 MRVI Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript
May 8 XENE Xenon Pharma Q1 2024 Earnings Preview
May 8 MRVI Maravai LifeSciences Holdings GAAP EPS of -$0.09 misses by $0.04, revenue of $64.2M beats by $3.65M
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags